In contrast, the survival time of patients with CCA was not significantly different (P = 0.224, P = 0.355, and P = 0.217 respectively by log-rank test) between high and low serum levels of CEA, CA19-9, and ALP (Figures 4B–D). Here, CEACAM5 is linked to cholangiocarcinoma.